STERIS Aktie
| 240,86USD | -1,03USD | -0,43% |
WKN DE: A2PGLV / ISIN: IE00BFY8C754
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 12 770 | 16 422 | 17 000 | 18 179 | 17 787 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,24 | 0,28 | 0,29 | 0,28 | 0,31 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 212 | 1 879 | 2 011 | 2 869 | 2 001 |
| Summe Anlagevermögen | 5 363 | 9 545 | 8 810 | 8 195 | 8 146 |
| Summe Aktiva | 6 574 | 11 424 | 10 822 | 11 064 | 10 147 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 2 683 | 4 879 | 4 735 | 4 748 | 3 531 |
| Summe Eigenkapital | 3 891 | 6 545 | 6 087 | 6 315 | 6 616 |
| Summe Passiva | 6 574 | 11 424 | 10 822 | 11 064 | 10 147 |
Adresse
| 70 Sir John Rogerson's Quay, 2 Dublin | |
| Internet | http://www.steris.com |
Management
|
Bill Brodbeck
Vice President-Regulatory Affairs |
|
Cary L. Majors
Senior Vice President & President-Healthcare |
|
Christopher S. Holland
Independent Director |
|
Cynthia L. Feldmann
Independent Director |
|
Daniel A. Carestio
President, Chief Executive Officer & Director |
|
Esther M. Alegria
Independent Director |
|
John Adam Zangerle
Secretary, Senior Vice President & General Counsel |
|
Julie Winter
VP-Investor Relations & Corporate Communications |
|
Karen Louise Burton
Chief Financial Officer & Senior Vice President |
|
Laura Weien
Vice President & Chief Compliance Officer |
|
Louis A. Shapiro
Independent Director |
|
Mary Clare Fraser
Chief Human Resources Officer & Senior VP |
|
Mohsen M. Sohi
Chairman |
|
Nirav R. Shah
Independent Director |
|
Paul E. Martin
Independent Director |
|
Renato G. Tamaro
Treasurer & Vice President |
|
Richard Carroll Breeden
Independent Director |
|
Walter M. Rosebrough
Chief Executive Officer-Emeritus |